383 related articles for article (PubMed ID: 36555154)
21. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
22. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.
Leitz J; Reuschenbach M; Lohrey C; Honegger A; Accardi R; Tommasino M; Llano M; von Knebel Doeberitz M; Hoppe-Seyler K; Hoppe-Seyler F
PLoS Pathog; 2014 Mar; 10(3):e1003957. PubMed ID: 24604027
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus (HPV) typing in relation to ras oncogene mRNA expression in HPV-associated human squamous cervical neoplasia.
Mammas IN; Zafiropoulos A; Sifakis S; Sourvinos G; Spandidos DA
Int J Biol Markers; 2005; 20(4):257-63. PubMed ID: 16398408
[TBL] [Abstract][Full Text] [Related]
25. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
26. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
Kolodkin-Gal D; Roitman L; Ovadya Y; Azazmeh N; Assouline B; Schlesinger Y; Kalifa R; Horwitz S; Khalatnik Y; Hochner-Ger A; Imam A; Demma JA; Winter E; Benyamini H; Elgavish S; Khatib AA; Meir K; Atlan K; Pikarsky E; Parnas O; Dor Y; Zamir G; Ben-Porath I; Krizhanovsky V
Gut; 2022 Feb; 71(2):345-355. PubMed ID: 33649045
[TBL] [Abstract][Full Text] [Related]
27. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
[TBL] [Abstract][Full Text] [Related]
28. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
29. Extremely stringent activation of p16INK4a prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expression.
Hang S; Tiwari AF; Ngan HY; Yip YL; Cheung AL; Tsao SW; Deng W
Oncotarget; 2016 Jul; 7(29):45656-45670. PubMed ID: 27344169
[TBL] [Abstract][Full Text] [Related]
30. The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis.
Andersson S; Mints M; Sällström J; Wilander E
Cancer Detect Prev; 2005; 29(1):37-41. PubMed ID: 15734215
[TBL] [Abstract][Full Text] [Related]
31. PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells.
Bossler F; Hoppe-Seyler K; Hoppe-Seyler F
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31058807
[TBL] [Abstract][Full Text] [Related]
32. Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM
EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087
[TBL] [Abstract][Full Text] [Related]
33. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
von Knebel Doeberitz M
Eur J Cancer; 2002 Nov; 38(17):2229-42. PubMed ID: 12441259
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic.
Al-Mansour F; Alraddadi A; He B; Saleh A; Poblocka M; Alzahrani W; Cowley S; Macip S
Aging (Albany NY); 2023 Mar; 15(7):2373-2394. PubMed ID: 36988504
[TBL] [Abstract][Full Text] [Related]
35. Targeting senescence as an anticancer therapy.
Bousset L; Gil J
Mol Oncol; 2022 Nov; 16(21):3855-3880. PubMed ID: 36065138
[TBL] [Abstract][Full Text] [Related]
36. Senescence and cancer - role and therapeutic opportunities.
Schmitt CA; Wang B; Demaria M
Nat Rev Clin Oncol; 2022 Oct; 19(10):619-636. PubMed ID: 36045302
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
[TBL] [Abstract][Full Text] [Related]
38. EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263.
Abdelgawad IY; Agostinucci K; Ismail SG; Grant MKO; Zordoky BN
Cells; 2022 Jun; 11(13):. PubMed ID: 35805077
[TBL] [Abstract][Full Text] [Related]
39. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.
Saleh T; Carpenter VJ; Bloukh S; Gewirtz DA
Semin Cancer Biol; 2022 Jun; 81():37-47. PubMed ID: 33358748
[TBL] [Abstract][Full Text] [Related]
40. Senescence-mediated anticancer effects of quercetin.
Özsoy Gökbilen S; Becer E; Vatansever HS
Nutr Res; 2022 Aug; 104():82-90. PubMed ID: 35635900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
